What is the main purpose of the Share Repurchase Agreement filed by HCA?

The main purpose of the Share Repurchase Agreement is for HCA to buy back $750 million of its own common stock from Hercules Holding II, LLC. This is a form of capital return to a significant shareholder and potentially helps in managing the company's share count and valuation.

Who is Hercules Holding II, LLC, and why is HCA repurchasing shares from them?

The filing does not explicitly state the relationship of Hercules Holding II, LLC to HCA, other than it is a party to the Share Repurchase Agreement. However, the significant size of the repurchase ($750 million) suggests Hercules is a major shareholder. HCA is repurchasing these shares as part of a strategy that appears to involve Hercules exiting or reducing its position through a secondary offering, with HCA buying back the shares.

How is the price of the repurchased shares determined?

The price per share for the repurchase is not fixed in advance. It will be equal to the price at which underwriters purchase shares from Hercules in a concurrent secondary offering. This means the repurchase price is market-driven and determined by the secondary offering's terms.

What does it mean that the repurchase is 'conditional upon settlement of the Secondary Offering'?

This means HCA will only complete its purchase of shares from Hercules if and when Hercules successfully completes its sale of shares to underwriters in the secondary offering. The two transactions are interdependent; one cannot happen without the other.

HCA 8-K: Material Agreements

Summary

This 8-K filing by HCA Healthcare, Inc. (HCA), dated May 20, 2014, primarily discloses a significant Share Repurchase Agreement entered into on May 14, 2014, with Hercules Holding II, LLC. Under this agreement, HCA committed to repurchasing $750 million worth of its common stock from Hercules. The repurchase is directly linked to and contingent upon the settlement of a concurrent secondary offering by Hercules. This transaction indicates a substantial return of capital to shareholders, specifically to Hercules, which appears to be a significant stakeholder. Investors should note that this repurchase is at a price determined by the underwriters in the secondary offering, suggesting a market-driven valuation for the shares being bought back. The filing highlights HCA's strategic financial management and its commitment to optimizing its capital structure.

Key Highlights

1HCA Holdings, Inc. entered into a Share Repurchase Agreement valued at $750 million on May 14, 2014.
2The agreement is with Hercules Holding II, LLC, for the repurchase of HCA's common stock.
3The repurchase price per share will be determined by the underwriters in a concurrent secondary offering by Hercules.
4The settlement of HCA's share repurchase is conditional upon the settlement of the Secondary Offering.
5This action signifies a significant capital return to a major shareholder (Hercules).
6The filing was made on Form 8-K, indicating a material event for the company.
7The full Share Repurchase Agreement is included as an exhibit to the filing.

HCA Healthcare, Inc. 8-K Report, Material Agreement (May 20, 2014)

Summary

Key Highlights

Frequently Asked Questions